Showing results (1391-1400 of 2,709) with videos related to
Sort By:
Pageof 271
The Lancet. Infectious Diseases|November 29, 2024
Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trialRodney Dawson, Andreas H Diacon, Veronique De Jager, et al.The Lancet. Infectious Diseases|November 29, 2024
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic reviewWilliam Burman, Pauline Luczynski, C Robert Horsburgh, et al.The Lancet. Infectious Diseases|December 15, 2024
Embedding treatment in stronger care systemsAmanda Rojek, Joshua Fieggen, Amy Paterson, et al.The Lancet. Infectious Diseases|November 17, 2024
Adjunctive ivermectin mass drug administration for malaria control on the Bijagos Archipelago of Guinea-Bissau (MATAMAL): a quadruple-blinded, cluster-randomised, placebo-controlled trialHarry Hutchins, Elizabeth Pretorius, John Bradley, et al.The Lancet. Infectious Diseases|November 8, 2024
A case of disseminated autochthonous Cladophialophora bantiana infection in a renal transplant recipient in the UKSamuel W Mackrill, David C Schramm, Ali Amini, et al.The Lancet. Infectious Diseases|February 23, 2025
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouise Sigfrid, Xin Hui S Chan, Louella M R Kasbergen, et al.The Lancet. Infectious Diseases|October 26, 2024
Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trialYusuke Okada, Yuji Kumagai, Iori Okura, et al.The Lancet. Infectious Diseases|October 26, 2024
The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trialDídac Macià, Joseph J Campo, Chenjerai Jairoce, et al.The Lancet. Infectious Diseases|November 14, 2025
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trialSean W X Ong, Ruxandra Pinto, Robert K Mahar, et al.The Lancet. Infectious Diseases|November 7, 2025
Global, regional, and national burden of Chagas disease, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023Pageof 271